shadow_tr

News & Events

Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice

Proposed mechanisms of estrogen

Dr. Mauvais-Jarvis’ group publishes a study on the antidiabetic effects of a new FDA-approved menopausal treatment in preclinical models.
Full story

Louisiana’s First Clinical Data Research Network to be Developed Through PCORI Funding

The Louisiana Clinical Data Research Network (LACDRN) was recently approved for a funding award by the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand a health data network that will be part of PCORnet: the National Patient-Centered National Clinical Research Network. The LACDRN is one of 29 such networks that were approved nation-wide for a total of approximately $93.5 million from PCORI on Dec. 17, 2013, to form this new national resource that aims to boost the efficiency of health research.
Full story

Mesoblast Reports Positive Type 2 Diabetes Trial Results

The clinical trial Protocol #MSB-DM003 – “A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Tolerability of a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients with Type 2 Diabetes Sub-optimally Controlled on Metformin”, currently being conducted at Tulane by Dr. Vivian A. Fonseca, is reporting "an improvement in glycemic control as evidenced by reduction in hemoglobin A1c (HbA1c)."
Full story

 news-row-spacer

1430 Tulane Ave, New Orleans, LA 70112 504-988-5263 medsch@tulane.edu